257 related articles for article (PubMed ID: 30779419)
21. Expression of NK-Activating Receptor-NKp46/NCR1 on NK Cells in Patients with Severe Aplastic Anemia.
Fu R; Liu H; Zhang J; Liu C; Ding S; Li L; Wang H; Wang G; Song J; Shao Z
Clin Lab; 2015; 61(9):1221-9. PubMed ID: 26554241
[TBL] [Abstract][Full Text] [Related]
22. Interferon-γ production by tubulointerstitial human CD56
Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
[TBL] [Abstract][Full Text] [Related]
23. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
[TBL] [Abstract][Full Text] [Related]
24. Highly activated TRAIL
Jiang Y; Qin S; Wei X; Liu X; Guan J; Zhu H; Chang G; Chen Y; Lu H; Qian J; Wang Z; Shen M; Lin X
Immunol Lett; 2021 Apr; 232():9-19. PubMed ID: 33515618
[TBL] [Abstract][Full Text] [Related]
25. Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.
Bhardwaj S; Ahmad F; Wedemeyer H; Cornberg M; Schulze Zur Wiesch J; van Lunzen J; Sarin SK; Schmidt RE; Meyer-Olson D
Virol J; 2016 Apr; 13():67. PubMed ID: 27091211
[TBL] [Abstract][Full Text] [Related]
26. Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver.
Harmon C; Robinson MW; Fahey R; Whelan S; Houlihan DD; Geoghegan J; O'Farrelly C
Eur J Immunol; 2016 Sep; 46(9):2111-20. PubMed ID: 27485474
[TBL] [Abstract][Full Text] [Related]
27. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.
Korbel DS; Norman PJ; Newman KC; Horowitz A; Gendzekhadze K; Parham P; Riley EM
J Immunol; 2009 May; 182(10):6426-34. PubMed ID: 19414796
[TBL] [Abstract][Full Text] [Related]
28. [Interferon-α mediating the functional damage of CD56
Zhao XG; Liu JQ; Huang HN; Lu ZM; Bai ZR; Li X; Qi JJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):975-981. PubMed ID: 38101777
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry.
Ranganath T; Simpson LJ; Ferreira AM; Seiler C; Vendrame E; Zhao N; Fontenot JD; Holmes S; Blish CA
Front Immunol; 2020; 11():714. PubMed ID: 32391016
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-7 expression and its effect on natural killer cells in patients with multiple sclerosis.
Su N; Shi SX; Zhu X; Borazanci A; Shi FD; Gan Y
J Neuroimmunol; 2014 Nov; 276(1-2):180-6. PubMed ID: 25218211
[TBL] [Abstract][Full Text] [Related]
31. CD56
Shi A; Zhang X; Xiao F; Zhu L; Yan W; Han M; Luo X; Chen T; Ning Q
J Viral Hepat; 2018 Nov; 25(11):1352-1362. PubMed ID: 29888839
[TBL] [Abstract][Full Text] [Related]
32. CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis.
Pierson BA; Miller JS
Blood; 1996 Sep; 88(6):2279-87. PubMed ID: 8822949
[TBL] [Abstract][Full Text] [Related]
33. Decreased TIM-3 expression of peripheral blood natural killer cells in patients with severe aplastic anemia.
Zhang T; Yuan X; Liu C; Li Y; Liu H; Li L; Ding K; Wang T; Wang H; Shao Z; Fu R
Cell Immunol; 2017 Aug; 318():17-22. PubMed ID: 28637584
[TBL] [Abstract][Full Text] [Related]
34. Lower number and decreased function of natural killer cells in hepatitis B virus related acute-on-chronic liver failure.
Liu F; Duan X; Wan Z; Zang H; You S; Yang R; Liu H; Li D; Li J; Zhang Y; Xin S
Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):605-613. PubMed ID: 27053076
[TBL] [Abstract][Full Text] [Related]
35. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
Cooper MA; Fehniger TA; Turner SC; Chen KS; Ghaheri BA; Ghayur T; Carson WE; Caligiuri MA
Blood; 2001 May; 97(10):3146-51. PubMed ID: 11342442
[TBL] [Abstract][Full Text] [Related]
36. Invasive Surgery Impairs the Regulatory Function of Human CD56 bright Natural Killer Cells in Response to Staphylococcus aureus. Suppression of Interferon-γ Synthesis.
Reinhardt R; Pohlmann S; Kleinertz H; Hepner-Schefczyk M; Paul A; Flohé SB
PLoS One; 2015; 10(6):e0130155. PubMed ID: 26090673
[TBL] [Abstract][Full Text] [Related]
37. Imbalance between CD56+bright and CD56+dim natural killer cell subsets in the liver of patients with recurrent hepatitis C after liver transplantation.
Yamagiwa S; Sato Y; Ichida T; Setsu T; Tominaga K; Kamimura H; Tsuchiya A; Takamura M; Matsuda Y; Aoyagi Y
Biomed Res; 2014; 35(3):177-84. PubMed ID: 24942856
[TBL] [Abstract][Full Text] [Related]
38. Activation status of CD56
Liu M; Liu J; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2021 Mar; 40(3):1103-1112. PubMed ID: 32797360
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients.
Mirjačić Martinović KM; Babović NLj; Džodić RR; Jurišić VB; Tanić NT; Konjević GM
Melanoma Res; 2014 Aug; 24(4):295-304. PubMed ID: 24769842
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.
Nielsen N; Ødum N; Ursø B; Lanier LL; Spee P
PLoS One; 2012; 7(2):e31959. PubMed ID: 22384114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
